Home > Name List By 4 > 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1- one Japan

CAS No 10457-90-6 , 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-
one Search by region : Japan

  • Name: 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-
    one
  • Synonyms: BRN 1552256; Bromoperidol; EINECS 233-943-3; CC 2489; Bromperidolum [INN-Latin]; 10457-90-6;Impromen; R 11333;4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-
    one;
  • CAS Registry Number:
  • Density: 1.366 g/cm3
  • Refractive index: 1.59
  • Hazard Symbols: Xn
  • EINECS: 233-943-3
  • Molecular Weight: 420.315223
  • InchiKey: RKLNONIVDFXQRX-UHFFFAOYSA-N
  • InChI: InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-
    2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
  • Risk Statements: 22
  • Molecular Formula: C21H23BrFNO2
  • Molecular Structure:CAS No:10457-90-6 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-<br />one

Select to

10457-90-6 Bromperidol

Contact Supplier

Select to

References of 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-
one
Title: Bromperidol
CAS Registry Number: 10457-90-6
CAS Name: 4-[4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
Synonyms: 4-[4-(p-bromophenyl)-4-hydroxypiperidino]-4¢-fluorobutyrophenone
Manufacturers' Codes: R-11333
Trademarks: Azurene (Cilag-Chemie); Impromen (Janssen); Tesoprel (Organon)
Molecular Formula: C21H23BrFNO2
Molecular Weight: 420.32
Percent Composition: C 60.01%, H 5.52%, Br 19.01%, F 4.52%, N 3.33%, O 7.61%
Literature References: Bromine analog of haloperidol, q.v. Prepn (no data): P. A. J. Janssen, GB 895309; idem, US 3438991 (1962, 1969 both to Janssen); C. J. E. Niemegeers, P. A. J. Janssen, Arzneim.-Forsch. 24, 45 (1974). Prepn of 82Br bromperidol and preliminary tissue distribution studies: S. H. Vincent et al., J. Med. Chem. 23, 75 (1980). Pharmacological study: C. J. E. Niemegeers, P. A. J. Janssen, Life Sci. 24, 2201 (1979). Preliminary clinical study: B. Woggon et al., Int. Pharmacopsychiatry 14, 213 (1979). Radioimmunoassay: E. Van Den Eeckhout et al., Eur. J. Drug Metab. Pharmacokinet. 5, 45 (1980).
Properties: Off-white amorphous or microcrystalline powder, mp 155-158°. uv max: 245 nm. pKa 8.6-8.7. Soly in water: 0.09 mg/ml; in 0.1M tartaric, lactic, citric and acetic acids: greater than or equal to 10 mg/ml.
Melting point: mp 155-158°
pKa: pKa 8.6-8.7
Absorption maximum: uv max: 245 nm
Therap-Cat: Antipsychotic.
Keywords: Antipsychotic; Butyrophenones.